Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Large-scale testing (Phase 3)Looking for participantsNCT06644781
What this trial is testing

Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Daiichi Sankyo 510
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193186
What this trial is testing

Anlotinib and Benmelstobart in DTC

Who this might be right for
Thyroid Cancer
Fudan University 23
Early research (Phase 1)Not Yet RecruitingNCT07583316
What this trial is testing

First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more
Corregene Biotechnology Co., Ltd 192
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446049
What this trial is testing

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Who this might be right for
Locally Advanced or Metastatic Solid TumorsPTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd. 180
Testing effectiveness (Phase 2)Looking for participantsNCT06172478
What this trial is testing

HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaHead and Neck Cancer+11 more
Daiichi Sankyo 740
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Early research (Phase 1)Not Yet RecruitingNCT05698238
What this trial is testing

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more
Mabpro, a.s. 50
Testing effectiveness (Phase 2)UnknownNCT01267578
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Early research (Phase 1)Study completedNCT02636036
What this trial is testing

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

Who this might be right for
Colorectal CancerSquamous Cell Carcinoma of the Head and NeckEpithelial Tumor
Akamis Bio 51
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Large-scale testing (Phase 3)Looking for participantsNCT06860971
What this trial is testing

AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 144
Not applicableTemporarily Not AvailableNCT03842865
What this trial is testing

Expanded Access of Vigil in Solid Tumors

Who this might be right for
Solid TumorEwing SarcomaEwing's Tumor Metastatic+5 more
Gradalis, Inc.
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Early research (Phase 1)Study completedNCT04670679
What this trial is testing

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Next Page